Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value of U2AF1 mutant in patients with de novo myelodysplastic syndromes: a meta-analysis.

Annals of hematology - 1 Dec 2019

Wang Huifang, Zhang Nanchen, Wu Xia, Zheng Xue, Ling Yantao, Gong Yuping

Abstract excerpt

U2 small nuclear RNA auxiliary factor 1 (U2AF1) mutant is the most common molecular biological abnormality in patients with myelodysplastic syndromes. Some studies have reported the prognostic impact of U2AF1 mutant in patients with de novo MDS, with discrepant results, so we do a meta-analysis about the relevant literatures to further investigate their prognostic impact on patients with de novo MDS. We conducted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Models, Biological

Share to Mutation

Share to Myelodysplastic Syndromes

Share to Neoplasm Proteins

Share to Splicing Factor U2AF

Share to Survival Rate

Source

Identifiers

PMID: 31754743
DOI: 10.1007/s00277-019-03843-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of U2AF1 mutant in patients with de novo myelodysplastic syndromes: a meta-analysis.PMID 31754743Read ↗

Prognostic significance of U2AF1 mutations in myelodysplastic syndromes: a meta-analysis.Semantic proximity Read ↗

The Biological and Clinical Consequences of RNA Splicing Factor U2AF1 Mutation in Myeloid MalignanciesSemantic proximity Read ↗

Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.Semantic proximity Read ↗

Prognostic value of SRSF2 mutations in patients with de novo myelodysplastic syndromes: A meta-analysis.Semantic proximity Read ↗

The Role of U2AF1 Mutation in Malignant Diseases and Related Therapeutic StrategiesSemantic proximity Read ↗

U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review).Semantic proximity Read ↗

U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes.Semantic proximity Read ↗

Impact of U2AF1 Pathogenic Variants on Prognosis of Myelodysplastic Neoplasms With RUNX1 Mutation.Semantic proximity Read ↗

Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome.Semantic proximity Read ↗

Association of Somatic Gene Mutations with Risk of Transformation into Acute Myeloid Leukemia in Patients with Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Distinct Mutation Landscapes Between Acute Myeloid Leukemia With Myelodysplasia-Related Changes and De Novo Acute Myeloid Leukemia.Semantic proximity Read ↗

[Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.